Skip to main content
Clinical Trials/NL-OMON31571
NL-OMON31571CompletedNot Applicable

Skin resident T cells in atopic dermatitis and psoriasis - Escape from regulation? - Skin resident T cells in atopic dermatitis and psoriasis

niversitair Medisch Centrum Utrecht0 sites48 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
48

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • - adult (18-70 years of age), male or female patients diagnosed with atopic dermatitis (diagnostic criteria as described by Williams), or (guttate or plaque) psoriasis
  • - biopsy location (about 2x2 cm) should not be treated with topical steroids for at least 1 week

Exclusion Criteria

  • - use of systemic immunosuppressive drugs (i.e., cyclosporin, prednisolone, methotrexate, neotigason, fumaric acid) in the 6 weeks prior to the inclusion
  • - exposure of biopsy location to (extraordinary) UV sunlight (i.e. UV-therapy, sunny holiday) in the 6 weeks prior to inclusion
  • - (secondary) skin infection

Investigators

Sponsor
niversitair Medisch Centrum Utrecht

Similar Trials

Skin resident T cells in atopic dermatitis... | Clinical Trial